Błaszczyk E, Gawlik A. Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(3).
APA
Błaszczyk, E., & Gawlik, A. (2016). Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism, 22(3).
Chicago
Błaszczyk, Ewa, and Aneta Gawlik. 2016. "Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?". Pediatric Endocrinology Diabetes and Metabolism 22 (3).
Harvard
Błaszczyk, E., and Gawlik, A. (2016). Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism, 22(3).
MLA
Błaszczyk, Ewa et al. "Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?." Pediatric Endocrinology Diabetes and Metabolism, vol. 22, no. 3, 2016.
Vancouver
Błaszczyk E, Gawlik A. Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(3).
